XML 34 R18.htm IDEA: XBRL DOCUMENT v3.25.3
Fair Value Measurements and Fair Value of Financial Instruments (Tables)
9 Months Ended
Sep. 30, 2025
Fair Value Disclosures [Abstract]  
Schedule of Cash Equivalents and Short-term Investments
The following is a summary of the Company’s cash equivalents and short-term investments:
September 30, 2025
Amortized
Cost Basis
Unrealized
Gains
Unrealized
Losses
Estimated
Fair Value
(In thousands)
Level 1:
Money market funds
$10,145 $— $— $10,145 
Level 2:
Commercial paper
10,987 — (1)10,986 
Total cash equivalents and short-term investments21,132 — (1)21,131 
Less: Cash equivalents(21,132)— (21,131)
Total short-term investments$— $— $— $— 
December 31, 2024
Amortized
Cost Basis
Unrealized
Gains
Unrealized
Losses
Estimated
Fair Value
(In thousands)
Level 1:
Money market funds$165 $— $— $165 
Level 2:
Commercial paper78,500 10 (9)78,501 
U.S. government and agency securities41,210 56 — 41,266 
Total cash equivalents and short-term investments119,875 66 (9)119,932 
Less: Cash equivalents(54,901)— (54,893)
Total short-term investments$64,974 $66 $(1)$65,039